106 related articles for article (PubMed ID: 20736794)
1. Matrix metalloproteinases that associate with and cleave bone morphogenetic protein-2 in vitro are elevated in hypertrophic fracture nonunion tissue.
Fajardo M; Liu CJ; Ilalov K; Egol KA
J Orthop Trauma; 2010 Sep; 24(9):557-63. PubMed ID: 20736794
[TBL] [Abstract][Full Text] [Related]
2. Matrix metalloproteinases and failed fracture healing.
Henle P; Zimmermann G; Weiss S
Bone; 2005 Dec; 37(6):791-8. PubMed ID: 16199217
[TBL] [Abstract][Full Text] [Related]
3. [Effect of brain injury on expression of bone morphogenetic protein 2 in fracture healing process].
Guo Q; Zhang L
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2007 Oct; 21(10):1040-4. PubMed ID: 17990765
[TBL] [Abstract][Full Text] [Related]
4. Colocalization of noggin and bone morphogenetic protein-4 during fracture healing.
Yoshimura Y; Nomura S; Kawasaki S; Tsutsumimoto T; Shimizu T; Takaoka K
J Bone Miner Res; 2001 May; 16(5):876-84. PubMed ID: 11341332
[TBL] [Abstract][Full Text] [Related]
5. Tumor necrosis factor alpha (TNF-alpha) coordinately regulates the expression of specific matrix metalloproteinases (MMPS) and angiogenic factors during fracture healing.
Lehmann W; Edgar CM; Wang K; Cho TJ; Barnes GL; Kakar S; Graves DT; Rueger JM; Gerstenfeld LC; Einhorn TA
Bone; 2005 Feb; 36(2):300-10. PubMed ID: 15780956
[TBL] [Abstract][Full Text] [Related]
6. Human hypertrophic nonunion tissue contains mesenchymal progenitor cells with multilineage capacity in vitro.
Iwakura T; Miwa M; Sakai Y; Niikura T; Lee SY; Oe K; Hasegawa T; Kuroda R; Fujioka H; Doita M; Kurosaka M
J Orthop Res; 2009 Feb; 27(2):208-15. PubMed ID: 18752274
[TBL] [Abstract][Full Text] [Related]
7. FGF23 is a putative marker for bone healing and regeneration.
Goebel S; Lienau J; Rammoser U; Seefried L; Wintgens KF; Seufert J; Duda G; Jakob F; Ebert R
J Orthop Res; 2009 Sep; 27(9):1141-6. PubMed ID: 19215029
[TBL] [Abstract][Full Text] [Related]
8. Genetic expression of extracellular matrix proteins correlates with histologic changes during fracture repair.
Jingushi S; Joyce ME; Bolander ME
J Bone Miner Res; 1992 Sep; 7(9):1045-55. PubMed ID: 1414497
[TBL] [Abstract][Full Text] [Related]
9. Expression of MMPs and TIMPs in human pterygia and cultured pterygium epithelial cells.
Di Girolamo N; McCluskey P; Lloyd A; Coroneo MT; Wakefield D
Invest Ophthalmol Vis Sci; 2000 Mar; 41(3):671-9. PubMed ID: 10711680
[TBL] [Abstract][Full Text] [Related]
10. Bone morphogenetic protein 2 and decorin expression in old fracture fragments and surrounding tissues.
Han XG; Wang DK; Gao F; Liu RH; Bi ZG
Genet Mol Res; 2015 Sep; 14(3):11063-72. PubMed ID: 26400336
[TBL] [Abstract][Full Text] [Related]
11. The systemic angiogenic response during bone healing.
Weiss S; Zimmermann G; Pufe T; Varoga D; Henle P
Arch Orthop Trauma Surg; 2009 Jul; 129(7):989-97. PubMed ID: 19037648
[TBL] [Abstract][Full Text] [Related]
12. Time profiles of the expression of metalloproteinases, tissue inhibitors of metalloproteases, cytokines and collagens in hamsters infected with Opisthorchis viverrini with special reference to peribiliary fibrosis and liver injury.
Prakobwong S; Pinlaor S; Yongvanit P; Sithithaworn P; Pairojkul C; Hiraku Y
Int J Parasitol; 2009 Jun; 39(7):825-35. PubMed ID: 19168069
[TBL] [Abstract][Full Text] [Related]
13. Hepatocyte growth factor contributes to fracture repair by upregulating the expression of BMP receptors.
Imai Y; Terai H; Nomura-Furuwatari C; Mizuno S; Matsumoto K; Nakamura T; Takaoka K
J Bone Miner Res; 2005 Oct; 20(10):1723-30. PubMed ID: 16160730
[TBL] [Abstract][Full Text] [Related]
14. The effect of IL-1alpha on the expression of matrix metalloproteinases, plasminogen activators, and their inhibitors in osteoblastic ROS 17/2.8 cells.
Fujisaki K; Tanabe N; Suzuki N; Mitsui N; Oka H; Ito K; Maeno M
Life Sci; 2006 Mar; 78(17):1975-82. PubMed ID: 16313928
[TBL] [Abstract][Full Text] [Related]
15. Levels of expression for BMP-7 and several BMP antagonists may play an integral role in a fracture nonunion: a pilot study.
Fajardo M; Liu CJ; Egol K
Clin Orthop Relat Res; 2009 Dec; 467(12):3071-8. PubMed ID: 19597895
[TBL] [Abstract][Full Text] [Related]
16. Analysis of expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human ciliary body after latanoprost.
Oh DJ; Martin JL; Williams AJ; Peck RE; Pokorny C; Russell P; Birk DE; Rhee DJ
Invest Ophthalmol Vis Sci; 2006 Mar; 47(3):953-63. PubMed ID: 16505029
[TBL] [Abstract][Full Text] [Related]
17. Expression profiles and clinical correlations of degradome components in the tumor microenvironment of head and neck squamous cell carcinoma.
Stokes A; Joutsa J; Ala-Aho R; Pitchers M; Pennington CJ; Martin C; Premachandra DJ; Okada Y; Peltonen J; Grénman R; James HA; Edwards DR; Kähäri VM
Clin Cancer Res; 2010 Apr; 16(7):2022-35. PubMed ID: 20305301
[TBL] [Abstract][Full Text] [Related]
18. Revision with dynamic compression plate and cancellous bone graft for aseptic nonunion after surgical treatment of humeral shaft fracture.
Lin CL; Fang CK; Chiu FY; Chen CM; Chen TH
J Trauma; 2009 Dec; 67(6):1393-6. PubMed ID: 20009693
[TBL] [Abstract][Full Text] [Related]
19. Ultraviolet radiation and the role of matrix metalloproteinases in the pathogenesis of ocular surface squamous neoplasia.
Ng J; Coroneo MT; Wakefield D; Di Girolamo N
Invest Ophthalmol Vis Sci; 2008 Dec; 49(12):5295-306. PubMed ID: 18641285
[TBL] [Abstract][Full Text] [Related]
20. Deficiency of inducible and endothelial nitric oxide synthase results in diminished bone formation and delayed union and nonunion development.
Meesters DM; Neubert S; Wijnands KAP; Heyer FL; Zeiter S; Ito K; Brink PRG; Poeze M
Bone; 2016 Feb; 83():111-118. PubMed ID: 26555548
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
